Kabafusion, Llc
KabaFusion is a national home and alternative site infusion provider delivering IVIG, SCIG, IV antibiotics, and parenteral nutrition across 45 states through 33 pharmacies and 21 ambulatory infusion suites, serving adult and pediatric patients with chronic immune, neuromuscular, and dermatological conditions.
- Company typePrivate
- Founded2010
- HeadquartersLexington, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Kabafusion, Llc does
KabaFusion, founded in 2010 by Dr. Sohail Masood, is a national provider of home and alternative site infusion therapy services and operates as the largest privately held home infusion company in the United States. The company specializes in intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) therapies for chronic conditions — including primary immunodeficiency, neuromuscular disorders (CIDP, GBS, MMN, myasthenia gravis), and dermatological diseases — alongside IV antibiotics, antifungals, and parenteral nutrition. Services are delivered through a network of 33 infusion pharmacies and 21 ambulatory infusion suites licensed across 45 states, supported by specially trained infusion nurses and pharmacists providing 24/7 clinical care. The company employs approximately 2,000 people and holds ACHC and URAC accreditations.
The core technology stack centers on a patient-facing mobile application (myKabaFusion) enabling care team communication, electronic document signing, monthly reordering, and planned telehealth and delivery tracking, complemented by telemonitoring for remote patient oversight. In September 2025, KabaFusion added an AI-powered referral management capability via a strategic partnership with Tennr to automate patient onboarding and reduce administrative friction.
KabaFusion generates revenue primarily through insurance reimbursement (Medicare, Medicaid, and commercial payors) for clinical infusion services and the dispensing of specialty infusion medications, with pricing varying by drug, dose, site of administration, and payor mix. The go-to-market model is sales-led and built on physician referrals, accelerated by rapid coverage verification turnaround and dedicated provider support. Following the February 2026 completion of a approximately $2.2 billion growth investment by Nautic Partners (acquiring from Novo Holdings), the clinician-led management team remains significant investors and continues to lead operations, with stated intent to expand market presence across the U.S. healthcare infusion sector.
Kabafusion, Llc firmographics
Firmographics- Name
- Kabafusion, Llc
- Legal name
- KabaFusion Holdings, LLC
- Website
- https://kabafusion.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- KabaFusion is a national home and alternative site infusion provider delivering IVIG, SCIG, IV antibiotics, and parenteral nutrition across 45 states through 33 pharmacies and 21 ambulatory infusion suites, serving adult and pediatric patients with chronic immune, neuromuscular, and dermatological conditions.
- Ownership category
- akta.pro rank
Kabafusion, Llc industry classification
Industry- Product category
- Home Infusion Therapy Services
- NAICS
- All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Infusion Therapy Centers (Outpatient) (HLAFABAF), Home Infusion Therapy & IV Nursing Services (HLADAFAG), Home Infusion Therapy Providers (HLAFAEAE), IV Therapy, Infusion & Injection Services (Home-Based) (HSABACAF), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
Keywords
Where Kabafusion, Llc is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Kabafusion, Llc business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Home Infusion Therapy Services: KabaFusion generates revenue by providing home and alternative site infusion therapies including IVIG, antibiotics, antifungals, parenteral nutrition, and other specialty medications. Services are reimbursed by insurance payors including Medicare, Medicaid, and commercial insurance. The company serves patients across 45 states through its network of infusion pharmacies and ambulatory infusion suites.
- Pharmacy Services and Specialty Medications: Compounding and dispensing specialty infusion medications through licensed pharmacies, with reimbursement through pharmacy benefits.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance-reimbursed infusion therapy — no publicly listed pricing; costs covered by Medicare, Medicaid, and commercial insurers |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Kabafusion, Llc product offering
Product offeringCore offering
KabaFusion operates a national specialty infusion pharmacy platform that provides home and ambulatory-site infusion therapies for patients with chronic and acute conditions. The company dispenses and administers IVIG/SCIG, IV antibiotics, parenteral nutrition, and condition-specific treatments for primary immunodeficiency, neuromuscular disorders, and dermatological diseases across 33 infusion pharmacies and 21 ambulatory infusion suites in 45 states.
Product overview
KabaFusion is a national provider of home and alternative site infusion therapies offering a comprehensive portfolio of services centered around intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) treatments. The company's core offerings include Home Infusion (IVIG & SCIG) as the primary service, supported by specialized treatment programs for Primary Immunodeficiency, Neuromuscular Disorders (CIDP, GBS, MMN, MG, Dermatomyositis), Dermatological Diseases, IV Antibiotics, and Nutritional Therapy (Parenteral Nutrition). KabaFusion complements its clinical services with the myKabaFusion mobile application for patient care coordination and Telemonitoring for remote patient monitoring. The company serves patients across 45 states through a network of home infusion pharmacies, alternative infusion sites, and home health agencies.
Differentiator
Problem solved
Functional benefit
Products and services
- Home Infusion Therapy (IVIG and SCIG) Specialty home infusion service delivering intravenous (IVIG) and subcutaneous (SCIG) immunoglobulin therapy to adult and pediatric patients with antibody deficiencies and related disorders, dispensed through KabaFusion's network of infusion pharmacies and administered by specialty infusion nurses.
- IV Antibiotic Therapy Home and ambulatory-site administration of intravenous antibiotics for patients requiring long-term antimicrobial therapy, including complex infections that can be safely managed outside of the hospital under KabaFusion specialty pharmacy oversight.
- Parenteral Nutrition Therapy Custom-formulated intravenous nutrition therapy delivered to patients in home or ambulatory settings who cannot maintain adequate nutrition through oral or enteral feeding, supported by KabaFusion's specialty pharmacy compounding and clinical monitoring.
- Dermatological Disease Infusion Therapy Condition-specific infusion therapy for patients with dermatological disorders (such as atopic dermatitis), provided via KabaFusion's specialty pharmacy and home/ambulatory infusion services.
- Neuromuscular Disorder Infusion Therapy Condition-specific infusion therapy for patients with neuromuscular disorders, including myasthenia gravis and CIDP, delivered through KabaFusion's home infusion pharmacy and ambulatory infusion suite network.
- Primary Immunodeficiency Infusion Therapy Specialty infusion therapy for patients diagnosed with primary immunodeficiency diseases (PI), including dispensing and home administration of subcutaneous immunoglobulin (SCIG) medications such as CUVITRU, supported by KabaFusion specialty pharmacy and nursing staff.
- myKabaFusion App Patient-facing mobile application used by home infusion patients to support communication, scheduling, and engagement with KabaFusion's specialty pharmacy and nursing services.
- Telemonitoring Remote patient monitoring service paired with home infusion therapy, enabling clinical staff to observe patients during infusions and intervene when needed.
Companies that use Kabafusion, Llc
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Kabafusion, Llc technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Kabafusion, Llc partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered strategic, significant, minor and core.
- TennrstrategicKabaFusion partnered with Tennr, a healthcare technology company that automates patient processing for referral-based care, to use AI-powered automation and data-driven insights to streamline care coordination, reduce administrative delays in patient onboarding, drive operational efficiencies, and improve patient outcomes. Tennr has raised over $160M from investors including IVP, Andreessen Horowitz (a16z), and Lightspeed Venture Partners.
- Memorial Hermann Health SystemsignificantMemorial Hermann joined existing investors in KabaFusion and will offer home infusion therapy for patients with chronic conditions through the partnership, enhancing access to KabaFusion's services within the Memorial Hermann network.
- Coram (CVS Health)minorKabaFusion closed a transaction with Coram to acquire 6 pharmacy and ambulatory infusion suite locations, consistent with Coram's previously announced downsizing. This expanded KabaFusion's nationwide footprint of patient-focused services.
- GC Biopharma USA, Inc.coreKabaFusion was selected by GC Biopharma as a Limited Distribution Partner for ALYGLO, an immune globulin subcutaneous treatment for adults with primary humoral immunodeficiency (PI), expanding KabaFusion's portfolio of specialty distribution partnerships.
- Lincare (owned by AdaptHealth)minorKabaFusion acquired Lincare's infusion pharmacies, expanding its patient-focused home infusion services nationally through strategic acquisition.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Kabafusion, Llc competitors and assessment
Company assessmentDirect peers
- Vivere Health: Specialty home infusion provider focused on IVIG, biologics, and rare disease therapies. Closely comparable mid-market peer competing with KabaFusion in specialty immunoglobulin and chronic condition infusion.
- Soleo Health: Specialty infusion services provider focused on immunoglobulin, anti-infective, and biologic therapies delivered in home and alternative site settings. Closely comparable mid-sized independent home infusion peer to KabaFusion.
- Amerita (BrightSpring Health Services): Specialty and home infusion pharmacy offering IVIG, TPN, and chronic disease infusion therapies. A direct competitor to KabaFusion in the home infusion segment with overlapping therapy mix and payor contracts.
- Option Care Health: Largest publicly traded independent home and alternate site infusion services provider in the U.S., offering IVIG, antibiotics, and specialty injectable therapies. Direct competitor to KabaFusion across home infusion and ambulatory infusion suites nationwide.
- Shields Health Solutions: Specialty pharmacy integrator focused on embedded hospital outpatient pharmacy and infusion services. Overlaps with KabaFusion in specialty injectable fulfillment and health system partnerships.
- Amedisys Home Infusion: Home health and infusion services provider with home infusion pharmacy operations. Competes with KabaFusion for home-based IVIG and antibiotic infusion referrals, especially in the post-acute setting.
Emerging players
- InfuSystem Holdings: Provider of infusion pumps and related clinical services in pain management and post-surgical care. Adjacent peer sharing the home/site-of-care infusion channel but with a different therapeutic focus.
Broad incumbents
- Coram (CVS Health): CVS Health's home infusion and specialty infusion subsidiary, operating a national network of pharmacies and ambulatory suites. KabaFusion directly acquired 6 Coram locations in 2025 amid Coram's downsizing, evidencing head-to-head overlap.
- Optum Infusion Pharmacy (UnitedHealth/Optum Rx): Specialty and home infusion pharmacy owned by UnitedHealth Group's Optum. Competes with KabaFusion in IVIG and specialty injectable therapy and benefits from payor-aligned patient steering.
Others
- Memorial Hermann Health System: Major nonprofit Texas health system and a strategic investor/partner of KabaFusion. Represented as a peer because it is both a customer and an investor, illustrating health-system-owned infusion channels that compete or partner with independent home infusion operators.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kabafusion, Llc compliance and trust
Trust signalCompliance3 records
Kabafusion, Llc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kabafusion, Llc leadership team
Management profileNumber of profiles
Profiles3 records
Kabafusion, Llc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kabafusion, Llc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kabafusion, Llc
What does Kabafusion, Llc do?
KabaFusion operates a national specialty infusion pharmacy platform that provides home and ambulatory-site infusion therapies for patients with chronic and acute conditions. The company dispenses and administers IVIG/SCIG, IV antibiotics, parenteral nutrition, and condition-specific treatments for primary immunodeficiency, neuromuscular disorders, and dermatological diseases across 33 infusion pharmacies and 21 ambulatory infusion suites in 45 states.
Is Kabafusion, Llc a public or private company?
Kabafusion, Llc is a private company. It is classified as private equity controlled and is currently operating.
When was Kabafusion, Llc founded?
Kabafusion, Llc was founded in 2010. It employs 1,001 to 5,000 people.
Where is Kabafusion, Llc based?
Kabafusion, Llc is headquartered in Lexington, United States, in the North America region.
How does Kabafusion, Llc make money?
Two revenue lines are on record. Home Infusion Therapy Services are the primary driver. The others are pharmacy Services and Specialty Medications.
Who are Kabafusion, Llc's main competitors?
Direct peers on record are Vivere Health, Soleo Health, Amerita (BrightSpring Health Services), Option Care Health, Shields Health Solutions and Amedisys Home Infusion. InfuSystem Holdings is listed as an emerging player. Broad incumbents are Coram (CVS Health) and Optum Infusion Pharmacy (UnitedHealth/Optum Rx). Memorial Hermann Health System is listed as an others.
Does Kabafusion, Llc have an API?
No public API is recorded for Kabafusion, Llc.
What industry is Kabafusion, Llc in?
Kabafusion, Llc's product category is Home Infusion Therapy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFABAF, Infusion Therapy Centers (Outpatient). Its NAICS code is 621498 and its SIC code is 8093.